Xeris Biopharma Holdings, Inc.

XERS

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001867096

SEC filings (opens in a new tab)

In the last 90 days, Xeris Biopharma Holdings, Inc. insiders filed 0 open-market purchases and 10 sales; 242 institutions reported holding it in 13F filings for Q2 2026, worth $857.1M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Xeris Biopharma Holdings, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of XERS: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Of which not filed for Q1 2022	Q1 2022	Change
Holders	92	1	103	+12
Shares	41.0M	1.40K	50.5M	+9.44M (+23.0%)
Value	$120.2M	$4.00K	$129.2M	+$8.99M (+7.5%)

1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to XERS in Q1 2022
Institution	Shares	Value	% of portfolio
Armistice Capital, LLC	7,464,993	$19.1M	0.54%
Two Sigma Investments, LP	150,109	$384.0K	0.00%
D. E. Shaw & Co., Inc.	149,046	$382.0K	0.00%
Yakira Capital Management, Inc.	117,076	$300.0K	0.04%
LMR Partners LLP	107,355	$275.0K	0.00%
Virtu Financial LLC	51,003	$131.0K	0.01%
Sciencast Management LP	35,934	$92.0K	0.02%
Connor, Clark & Lunn Investment Management Ltd.	28,897	$74.0K	0.00%
Ergoteles LLC	25,200	$65.0K	0.00%
Jump Financial, LLC	23,100	$59.0K	0.00%
Barclays PLC	21,788	$56.0K	0.00%
Old Mission Capital LLC	21,505	$55.0K	0.00%
Fifth Lane Capital, LP	17,513	$45.0K	0.03%
Shay Capital LLC	13,390	$34.0K	0.01%
Two Sigma Advisers, LP	12,900	$33.0K	0.00%
Schonfeld Strategic Advisors LLC	12,500	$32.0K	0.00%
CTC Capital Management, LLC	11,800	$30.0K	0.08%
Zurcher Kantonalbank (Zurich Cantonalbank)	10,751	$28.0K	0.00%
Running Point Capital Advisors, LLC	10,000	$26.0K	0.02%
Cutler Group LP	3,744	$9.00K	0.00%
Ovata Capital Management Ltd	2,200	$6.00K	0.00%
Signaturefd, LLC	1,445	$4.00K	0.00%
US Bancorp	444	$1.00K	0.00%
FMR LLC	503	$1.00K	0.00%
TCI Wealth Advisors, Inc.	200	$1.00K	0.00%
Federation des caisses Desjardins du Quebec	300	$768	0.00%
SOA Wealth Advisors, LLC.	118	$0	0.00%

Sold out (15)

Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of XERS in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
IHT Wealth Management, LLC	342,897	$1.00M
Aristides Capital LLC	100,080	$293.0K
Kamunting Street Capital Management, L.P.	64,539	$189.0K
GPS Wealth Strategies Group, LLC	59,025	$173.0K
FNY Investment Advisers, LLC	49,088	$143.0K
Caption Management, LLC	47,600	$140.0K
Evercore Wealth Management, LLC	38,801	$114.0K
Belvedere Trading LLC	47,282	$103.0K
Leonteq Securities AG	21,000	$61.5K
Avenue 1 Advisors, LLC	12,544	$37.0K
Raymond James & Associates	11,300	$33.0K
Aigen Investment Management, LP	10,586	$31.0K
Paloma Partners Management Co	10,066	$29.0K
TSFG, LLC	5,488	$16.0K
Northwestern Mutual Wealth Management Co	100	$0

Not filed for Q1 2022 yet (1)

Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding XERS in Q4 2021 that haven't filed for Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Sphinx Trading, LP	1,404	$4.00K